A carregar...

An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis

Assess the sensitivity of the Magnetic Resonance Disease Severity Scale (MRDSS), based on cerebral lesions and atrophy, for treatment monitoring of glatiramer acetate (GA) in relapsing-remitting multiple sclerosis (MS). This retrospective non-randomized pilot study included patients who started dail...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Neurol
Main Authors: Kim, Gloria, Tauhid, Shahamat, Dupuy, Sheena L., Tummala, Subhash, Khalid, Fariha, Healy, Brian C., Bakshi, Rohit
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2016
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4785194/
https://ncbi.nlm.nih.gov/pubmed/26754005
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00415-015-8009-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!